Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Location status: Recruiting
NCT Number: NCT06373861
GALAXY is a registry research study that plans to learn more about individuals with X&Y variations (also called sex chromosome aneuploidies) through collecting information from medical records.This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. The purpose of the GALAXY Registry is to collect and store this information with the overall goal to improve health outcomes in individuals with X&Y variations and the care they receive.
Interested in participating?
Request Info0 day–100 year
All sexes
Observational
Aurora, Colorado, 80045, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a. Lack of documentation of genetic testing confirming SCA diagnosis
This study is an observational study without treatment intervention.
Time frame: From study start until condition observed, up to 15 years
Average number of chronic diagnoses per person
Time frame: From study start until condition observed, up to 15 years
Prevalence of mental health diagnoses is defined as the number of participants in the sample diagnosed with a mental health disorder by a clinician according to their medical record out of the total sample. This will be determined by a diagnosis of any of the following in a clinical encounter, problem list, and/or past medical history:
Time frame: From study start until condition observed, up to 15 years
Prevalence of obesity is defined as the number of participants in the sample with obesity in their medical record out of the total sample. Obesity in pediatric populations is determined using BMI-for-age and obesity in adult populations is determined using BMI. BMI is calculated as the weight in kilograms divided by the height in meters squared.
Participants will be considered to have obesity if:
Time frame: From study start until condition observed, up to 15 years
Prevalence of metabolic syndrome is defined as the number of participants in the sample with dyslipidemia in their medical record out of the total sample. Dyslipidemia will be defined as:
Time frame: From study start until condition observed, up to 15 years
Prevalence of hypertension is defined as the number of participants in the sample with evidence of hypertension in their medical record out of the total sample. Evidence of hypertension includes:
Time frame: From study start until condition observed, up to 15 years
Prevalence of hypothyroidism is defined as the number of participants in the sample with evidence of hypertension in their medical record out of the total sample.
Time frame: From study start until condition observed, up to 15 years
Prevalence of diabetes is defined as the number of participants in the sample with evidence of hypertension in their medical record out of the total sample. Both type 1 and type 2 are included.
Contact information is provided by the study sponsor or research team.
University of Colorado, Denver
Other
Generating Advancements Through Longitudinal Analysis in X and Y Variations
Acronym: GALAXY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02723305
47,XXY, Chromosome Disorders
Aurora, Colorado, United States
View Trial DetailsNCT07718997
47, XYY syndrome, Cardiovascular Abnormalities
Oslo, Norway
View Trial DetailsNCT05586802
Chromosome Disorders, Congenital Abnormalities
Lausanne, Switzerland
View Trial DetailsNCT05581147
Autoimmune Diseases, Chromosome Disorders
Roma, Italy
View Trial Details